[go: up one dir, main page]

HRP20040643A2 - Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors - Google Patents

Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors Download PDF

Info

Publication number
HRP20040643A2
HRP20040643A2 HR20040643A HRP20040643A HRP20040643A2 HR P20040643 A2 HRP20040643 A2 HR P20040643A2 HR 20040643 A HR20040643 A HR 20040643A HR P20040643 A HRP20040643 A HR P20040643A HR P20040643 A2 HRP20040643 A2 HR P20040643A2
Authority
HR
Croatia
Prior art keywords
substituted
group
4alkyl
methyl
nr5r5a
Prior art date
Application number
HR20040643A
Other languages
English (en)
Croatian (hr)
Inventor
M. Tarby Christine
Original Assignee
Bristol-Myers Squibb Company A Delaware (Usa) Corp
Oration
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol-Myers Squibb Company A Delaware (Usa) Corp, Oration filed Critical Bristol-Myers Squibb Company A Delaware (Usa) Corp
Publication of HRP20040643A2 publication Critical patent/HRP20040643A2/hr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HR20040643A 2002-01-18 2004-07-13 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors HRP20040643A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34964102P 2002-01-18 2002-01-18
PCT/US2003/001604 WO2003062238A1 (en) 2002-01-18 2003-01-16 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
HRP20040643A2 true HRP20040643A2 (en) 2005-04-30

Family

ID=27613304

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20040643A HRP20040643A2 (en) 2002-01-18 2004-07-13 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors

Country Status (21)

Country Link
US (2) US6844340B2 (sh)
EP (1) EP1474424A4 (sh)
JP (1) JP2005519910A (sh)
KR (1) KR20040077735A (sh)
CN (1) CN1642954A (sh)
AR (1) AR038164A1 (sh)
BR (1) BR0306927A (sh)
CA (1) CA2473420A1 (sh)
CO (1) CO5590961A2 (sh)
HR (1) HRP20040643A2 (sh)
IL (1) IL162743A0 (sh)
IS (1) IS7341A (sh)
MX (1) MXPA04006948A (sh)
NO (1) NO20043424L (sh)
PE (1) PE20030987A1 (sh)
PL (1) PL371418A1 (sh)
RU (1) RU2004125151A (sh)
TW (1) TW200306192A (sh)
WO (1) WO2003062238A1 (sh)
YU (1) YU62504A (sh)
ZA (1) ZA200405139B (sh)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
AR039540A1 (es) * 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
KR20110132482A (ko) 2003-02-07 2011-12-07 얀센 파마슈티카 엔.브이. Hiv 감염 예방용 피리미딘 유도체
WO2008004100A2 (en) 2006-07-05 2008-01-10 Pfizer Products Inc. Therapeutic compounds
US20080119552A1 (en) * 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
KR101709141B1 (ko) 2008-01-25 2017-02-22 브이티브이 테라퓨틱스 엘엘씨 TNF-α 합성의 조절자 및 PDE4 억제제로서 3고리 화합물
ES2475970T3 (es) 2009-12-23 2014-07-11 Katholieke Universiteit Leuven Novedosos compuestos antivirales
KR20140003438A (ko) 2010-11-15 2014-01-09 카톨리에케 유니버시테이트 루벤 항바이러스성 축합 헤테로사이클릭 화합물
CN103429595B (zh) 2010-11-15 2015-10-21 Viiv保健英国有限公司 Hiv复制的抑制剂
CN103130787B (zh) * 2011-11-24 2015-06-10 南开大学 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593337B1 (en) * 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
US6596729B2 (en) 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
ZA200405139B (en) 2006-02-22
WO2003062238A1 (en) 2003-07-31
IL162743A0 (en) 2005-11-20
MXPA04006948A (es) 2004-12-06
EP1474424A1 (en) 2004-11-10
US20030162800A1 (en) 2003-08-28
EP1474424A4 (en) 2005-12-28
CO5590961A2 (es) 2005-12-30
TW200306192A (en) 2003-11-16
BR0306927A (pt) 2004-11-09
IS7341A (is) 2004-06-30
US7186830B2 (en) 2007-03-06
PL371418A1 (en) 2005-06-13
CA2473420A1 (en) 2003-07-31
JP2005519910A (ja) 2005-07-07
US20040266778A1 (en) 2004-12-30
YU62504A (sh) 2006-08-17
CN1642954A (zh) 2005-07-20
RU2004125151A (ru) 2006-02-20
NO20043424L (no) 2004-08-18
PE20030987A1 (es) 2003-11-15
AR038164A1 (es) 2004-12-29
KR20040077735A (ko) 2004-09-06
US6844340B2 (en) 2005-01-18

Similar Documents

Publication Publication Date Title
US6593337B1 (en) Tricyclic compounds useful as HIV reverse transcriptase inhibitors
US6809109B2 (en) 2, 4-disubstituted-pyridine N-oxides useful as HIV reverse transcriptase inhibitors
HRP20040643A2 (en) Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors
EP1379248A1 (en) Tricyclic compounds useful as hiv reverse transcriptase inhibitors
US6204262B1 (en) 1,3-Benzodiazepin-2-ones and 1,3-Benzoxazepin-2-ones useful as HIV reverse transcriptase inhibitors
US20020107261A1 (en) Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
US6462037B1 (en) 1,4-benzodiazepin-2-ones useful as HIV reverse transcriptase inhibitors
AU2003203047A1 (en) Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
US20030220327A1 (en) Cyanamide, alkoxyamino, and urea derivatives of 1,3-benzodiazephine as HIV reverse transcriptase inhibitors
AU2002254652A1 (en) Tricyclic compounds useful as HIV reverse transcriptase inhibitors
CA2330110A1 (en) 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
ZA200203131B (en) Condensed naphthyridines as HIV reverse transcriptase inhibitors.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20061228

Year of fee payment: 5

OBST Application withdrawn